This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.

Background and Date of Approval

Telmisartan+cilnidipine is an antihypertensive drug. This combination has two active ingredients. Telmisartan belongs to the group of medications called angiotensin II receptor antagonists. Cilnidipine belongs to the class of medications called calcium channel blockers. The initial FDA approval was in 1998 for its medical uses. 

Mechanism of Action of undefined

Telmisartan+cilnidipine work by relaxing the blood vessels and making the pumping action of the heart efficient. The combination of both Telmisartan and cilnidipine lower blood pressure efficiently.

Uses of undefined

It is used to treat high blood pressure. It helps relax the blood vessels by making it easier for the heart to pump blood all over the body, lowering the risk of heart attack and stroke.

undefined Drug administaration and Dosage available

This medication is taken as per the advice of the doctor. It can be taken on an empty stomach or with food, but it has to be taken at the same time daily. It’s very important to take this medicine even if you feel well. As it causes ankle swelling, sitting by raising the leg upward is better. The dosage of this medication will depend upon the condition and how individuals respond to the medication. Avoid breaking or chewing the tablet. Instead, swallow it whole with a glass of water.

Warnings, Precautions and Side Effects of undefined

Warnings

Inform the doctor about any kidney or liver-related problems. If patients are breastfeeding mothers or planning for pregnancy, they must inform the doctor before starting this medication. While using this medication, blood pressure should be monitored regularly, and a kidney function test should be performed to note if there are any abnormal changes.

Precautions

This medication is taken as per the advice of the doctor. It can be taken on an empty stomach or with food, but it must be taken at a fixed time daily. It's very important to take this medicine even if you feel well. The dosage of this medication will depend upon the condition and how individuals respond to the medication. It acts by lowering blood pressure and reduces the risk of heart attack and stroke, so don't stop this medication without the proper advice of a doctor.

Inform your doctor about any medicines that you are taking or have taken before, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with telmisartan + cilnidipine and cause undesirable side effects. 

Side Effects

The common side effects of telmisartan + cilnidipine are fever, increased potassium level, tiredness, feeling sleepy, headaches, back pain, difficulty breathing, stomach upset, nausea, and muscle pain. Other serious side effects are swelling of ankles and feet, dizziness, vision change, and palpitation. 

Word Of Advice

Store away from light & moisture and maintain the temperature below 30ºC. Keep Telmisartan+cilnidipine out of sight and reach of children and pets. If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.

It is suggested to inform the doctor if a patient has any history of allergic reactions to avoid life-threatening complications. Tell the doctor before the treatment commencement if the patient is pregnant or has liver, kidney, or uterine problems. While using this medication, blood pressure should be monitored regularly, and a kidney function test should be performed to note if there are any abnormal changes.

Frequently Asked Question

References

  1. KD. Tripathi. Antianginal and other Anti-ischaemic Drugs & Drugs Affecting Renin-Angiotensin System. Eighth edition. June 2018. Page – 596 & 536.
  2. https://www.torrentian.com/pisheet/Upload/PI_Sheet/2909.pdf. Torrent Pharmaceuticals Ltd. Telsar N (Telmisartan and Cilnidipine Tablets). [Revised in April 2020] [Accessed on 29/10/2022] 
  3. https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/020850s011lbl.pdf (revised on 3/5/2011) (accessed on 29/10/2022)

Disclaimer

The drug information on this page is not a substitute for medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.